Intrinsic Value of S&P & Nasdaq Contact Us

Evotec SE EVO NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • DE • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.00
+124.4%

Stock Statistics — EVO

Evotec SE (EVO) has a market capitalization of $1.11B and trades at $3.12. The 52-week range is 2.31-4.8.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.6, Earnings Per Share (EPS) of $-0.56, annual revenue of $796.97M.

The stock has a beta of 1.12, operates in the Healthcare sector.

Trading Data
Current Price$3.12
52-Week Range2.31-4.8
Volume110.33K
Avg Volume (30D)141.99K
Market Cap$1.11B
Beta (1Y)1.12
Company
IPO Date2004-02-05
Employees4,766
CEOChristian Wojczewski
CountryDE
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS30050E1055
CUSIP30050E105
Income (Latest Year)
Revenue$796.97M
Gross Profit$114.88M
EBITDA$-80.66M
Operating Income$-142.52M
Net Income$-196.08M
EPS$-0.56
EPS Diluted$-0.56
Shares Outstanding$353.29M
Balance Sheet (Latest Year)
Total Assets$1.91B
Current Assets$681.96M
Cash & ST Investments$396.8M
Total Liabilities$959.98M
Total Debt$443.54M
Net Debt$137.15M
Total Equity$952.53M
Debt / Equity0.47
Valuation Ratios
P/E Ratio-5.6
P/S Ratio1.39
P/B Ratio1.16
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message